Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of ...

Q4 2024 Management View CEO Philippe Krakowsky reported a Q4 organic revenue decline of 1.8%, bringing full-year organic growth to 0.2%. He attributed this to intensified headwinds from trailing ...

Raregivers Emotional Journey Map Fondation Ipsen Joins as a Key Partner, Enabling Free Digital & Print Distribution of the RaregiversTM Emo ...

For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...

South San Francisco has seen leasing and activity in its life sciences real estate market decrease despite a bevy of new ...

Of all the risks associated with pharmaceuticals and medical devices, controlling contamination is one of the most important and difficult challenges. Relational risk analysis (ReRA) can help.

Pre-built spaces and a private club atmosphere are drawing tenants to Chelsea office building 28&7. Discover the strategy behind its leasing success.

While Ideaya is letting Amgen go, it is retaining an interest in MAT2A-PRMT5 combinations. Ideaya has a PRMT5 inhibitor, ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Shares of Amgen Inc. AMGN slipped 1.16% to $291.16 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and ...

Biotechnology company, Amgen, has announced that it has entered into a definitive agreement to acquire deCODE Genetics, a global leader in human genetics, for US $415 million. The all-cash ...